Moxifloxacin hydrochloride

A single experienced surgeon performed all the surgeries using the VisuMax FS laser system (Carl Zeiss Meditec AG, Jena, Germany) with a 500-kHz repetition rate under topical anesthesia (0.5% proparacaine hydrochloride, Sunways Pvt. Ltd., Maharashtra, India) instilled two to three times under aseptic precautions. Laser cut energy index was 170 nJ. Spot spacing was 2 μm for creation of the lenticule side cut and 4.5 μm for creation of the lenticule. Lenticule and cap diameter was 6.0 and 7.7 mm, respectively. Intended cap thickness was 110 μm. After the refractive lenticule was created, it was dissected and separated through the side-cut opening and removed manually. No fluid hydration or intraoperative massaging of the cornea was performed after lenticule removal. At the end of the procedure, the cornea was moistened with a wet merocel sponge. A drop of moxifloxacin hydrochloride 0.5% (Vigamox, Alcon Laboratories, Inc, Fort Worth, TX) was instilled in both eyes and the procedure was completed. Postoperative treatment included 0.5% moxifloxacin hydrochloride four times a day for 1 week, tapering dose of topical 1% prednisolone acetate suspension (Pred Forte, Allergan, Inc., Irvine, CA) starting from four times a day to once daily for 3 days each and a topical lubricant (Optive, Allergan, Inc.) four times a day for a month.